World Aquaculture Singapore 2026

June 2-5, 2026

Singapore

A UNIQUE ORGANIC ACID BLEND TO REDUCE DISEASE SEVERITY AND IMPROVE PROFITABILITY IN TILAPIA FARMING

I-Tung Chen*,  Alex Makol, Maria Mercè Isern-Subich and Waldo G. Nuez-Ortín

Adisseo S.A.S, France

i-tung.chen@adisseo.com



Bacterial diseases caused by species such as Vibrio , Lactococcus , and Streptococcus lead to major financial losses in fish farming. These risks are often increased by rising water temperatures and stressful rearing conditions. Many pathogens cause subclinical infections without showing clear signs, allowing the disease to spread unnoticed while slowing growth and raising production costs.  Organic acids  deliver bacterial inhibitory properties and  are often used to  support the health management strategy and bacterial control.

This  research evaluated an aqua -specific blend of organic acids (Bacti-Nil Aqua (BNA), Adisseo) to reduce the severity of bacterial infections  through a multi-stage approach, including laboratory tests, controlled challenges, and real farm condition trial .  Firstly, M inimum i nhibitory c oncentration (MIC) tests identified the smallest concentration of BNA needed to inhibit field isolates of Vibrio , Lactococcus , Streptococcus , and Carnobacterium from Asia, Europe, and South America. Secondly, i n a  controlled in vivo test, Nile tilapia with an initial body weight of 20 g were  first fed a diet supplemented with a preventive dose  of BNA  (0.2%) for 30 days, followed by a corrective dose (0.5%) during a 14-day co-infection with Aeromonas and Streptococcus . Finally, a commercial farm trial in Thailand evaluated growth performance and profitability in tilapia with an average initial body weight of 56.5 g over a 12-week culture period, reaching an average final weight of 540 g.

The MIC results showed that BNA effectively limited bacterial growth at concentrations of 1 to 5 m g/L. In  the controlled infections challenge, BNA reduced final mortality by 22%. The additive  successfully delayed the time to 50% mortality (LT50) by 34% and significantly reduced the bacterial load in the head kidney of challenged fish. The farm trial showed that BNA increased biomass gain  by 5% and  reduced  the f eed c onversion rate (FCR) by 3%, resulting in a return on investment (ROI) of 3.5.

In conclusion,  the dietary use of BNA at 0.2-0.5% showed  potential as an effective  health management  strategy for  reducing the severity of bacterial infections and ensured better growth and profitability.